Clinical Trials on Multiple Sclerosis, Relapsing Forms in United Kingdom
Total 1436 results
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing Forms of Multiple SclerosisSpain, Canada, France, Switzerland, Italy, Portugal, Denmark, Poland, Germany, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisAustralia, United States
-
MedImmune LLCCompletedMultiple Sclerosis, Relapsing FormsUnited States, Spain, Poland, Ukraine
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruiting
-
Emerald Health PharmaceuticalsSuspendedRelapsing Forms of Multiple SclerosisUnited States, Australia
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States, Italy, Switzerland, Canada, Australia, Germany, Spain, France, Portugal, Netherlands, United Kingdom, Denmark, Austria, Ireland
-
NHS Greater Glasgow and ClydeBiogenEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited Kingdom
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisGermany, South Africa, Italy, United States, Austria, Belgium, Czechia, Egypt, Hungary, Malaysia, Turkey, Spain, Australia, Canada, France, Israel, Netherlands, Switzerland, Greece, Korea, Republic of, Romania, Russian Federation, United... and more
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
BiogenRecruitingRelapsing Forms of Multiple SclerosisSpain, United States, Italy, Switzerland, Germany, Bulgaria, Czechia, Poland, Puerto Rico, Romania
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisUnited States, Canada, Puerto Rico
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom, Ireland
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
Waukesha Memorial HospitalThe Cleveland ClinicCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
University of North Carolina, Chapel HillGenzyme, a Sanofi CompanyTerminatedRELAPSING REMITTING MULTIPLE SCLEROSISUnited States
-
Ohio State UniversityNational Multiple Sclerosis SocietyCompleted
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
University of Missouri, Kansas CityCompletedRelapsing-remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityNational Multiple Sclerosis SocietyCompletedRelapsing-remitting Multiple SclerosisUnited States
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
NeurognosticsTerminatedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey